RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech was testing the MYR1.43 level lately. A bullish bias may be present above this point, with a target price of MYR1.50, followed by MYR1.60. The stock may consolidate further if it cannot breach above the MYR1.43 threshold decisively in the near term. Support may be found at MYR1.29, where traders can exit upon a breach to minimise the downside risk.
Source: RHB Securities Research - 8 Aug 2019
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-25 16:50:00
MACD/RSI
10 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 20
10 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 20
5 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 55
5 Mins
BUY
2024-11-25 15:40:00
EMA 5
10 Mins
BUY
Apps
Top Articles
1
2
3
TA Sector Research
4
Good Articles to Share
What’s behind the slew of restaurant bankruptcies in 2024? Experts unpack the problems
5
M+ Online Research Articles
6
Good Articles to Share
7
MQ Market Updates
8
Good Articles to Share
Four convicted in Spain over homophobic murder that sparked nationwode protests
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
